← Back to headlines
BridgeBio Pharma GAAP EPS of -$1.00 misses by $0.33, revenue of $154.2M beats by $5.13M
BridgeBio Pharma's GAAP EPS of -$1.00 missed estimates by $0.33, though its revenue of $154.2 million beat by $5.13 million.
24 Feb, 21:06 — 24 Feb, 21:06
Sources
Showing 1 of 1 sources
Related Stories
South Korea Central Bank Raises Rates to 3 Percent Amid Inflation Concerns
14m ago
Meta Agrees to $17 Billion Settlement Over Teen Mental Health Lawsuits
32m ago
Nvidia in Talks to Acquire AI Platform Hugging Face for Over $13 Billion
41m ago
Mesoblast Reports Strong Revenue Growth Amid Commercial Transition
55m ago